MAPK3 and Alzheimer disease: However, ERK1/2 is aberrantly overactivated in the brains of patients with AD and mouse models, which contributes to tau hyperphosphorylation, Aβ accumulation and subsequent synaptic and cognitive dysfunctions28–31.